West Midland Vascular Limited 12092698 false 2024-08-01 2025-07-31 2025-07-31 The principal activity of the company is Vascular consultants Digita Accounts Production Advanced 6.30.9574.0 true 12092698 2024-08-01 2025-07-31 12092698 2025-07-31 12092698 core:RetainedEarningsAccumulatedLosses 2025-07-31 12092698 core:RevaluationReserve 2025-07-31 12092698 core:ShareCapital 2025-07-31 12092698 core:FinancialAssetsDesignatedFairValueThroughProfitOrLoss core:Non-currentFinancialInstruments 2025-07-31 12092698 core:CurrentFinancialInstruments 2025-07-31 12092698 core:CurrentFinancialInstruments core:WithinOneYear 2025-07-31 12092698 core:Non-currentFinancialInstruments 2025-07-31 12092698 core:Non-currentFinancialInstruments core:AfterOneYear 2025-07-31 12092698 core:FurnitureFittings 2025-07-31 12092698 core:OfficeEquipment 2025-07-31 12092698 bus:SmallEntities 2024-08-01 2025-07-31 12092698 bus:AuditExemptWithAccountantsReport 2024-08-01 2025-07-31 12092698 bus:FilletedAccounts 2024-08-01 2025-07-31 12092698 bus:SmallCompaniesRegimeForAccounts 2024-08-01 2025-07-31 12092698 bus:RegisteredOffice 2024-08-01 2025-07-31 12092698 bus:Director1 2024-08-01 2025-07-31 12092698 bus:Director2 2024-08-01 2025-07-31 12092698 bus:PrivateLimitedCompanyLtd 2024-08-01 2025-07-31 12092698 bus:Agent1 2024-08-01 2025-07-31 12092698 core:RevaluationReserve 2024-08-01 2025-07-31 12092698 core:FurnitureFittings 2024-08-01 2025-07-31 12092698 core:OfficeEquipment 2024-08-01 2025-07-31 12092698 core:PlantMachinery 2024-08-01 2025-07-31 12092698 countries:AllCountries 2024-08-01 2025-07-31 12092698 2024-07-31 12092698 core:FurnitureFittings 2024-07-31 12092698 core:OfficeEquipment 2024-07-31 12092698 2023-08-01 2024-07-31 12092698 2024-07-31 12092698 core:RetainedEarningsAccumulatedLosses 2024-07-31 12092698 core:RevaluationReserve 2024-07-31 12092698 core:ShareCapital 2024-07-31 12092698 core:CurrentFinancialInstruments 2024-07-31 12092698 core:CurrentFinancialInstruments core:WithinOneYear 2024-07-31 12092698 core:Non-currentFinancialInstruments 2024-07-31 12092698 core:Non-currentFinancialInstruments core:AfterOneYear 2024-07-31 12092698 core:FurnitureFittings 2024-07-31 12092698 core:OfficeEquipment 2024-07-31 12092698 core:RevaluationReserve 2023-08-01 2024-07-31 iso4217:GBP xbrli:pure

Registration number: 12092698

West Midland Vascular Limited
Unaudited Filleted Financial Statements
for the Year Ended 31 July 2025

West Midland Vascular Limited

Contents

Company Information | 1
Balance Sheet | 2
Notes to the Unaudited Financial Statements | 3 to 7

West Midland Vascular Limited

Company Information

Directors | Mrs Gillian Bradbury Prof Andrew Bradbury

Registered office | Lapworth Farm Spring Lane Lapworth Warwickshire B94 5NS

Accountants | JS Accounting Services Ltd 13-15 Morningside Drive Edinburgh EH10 5LZ

West Midland Vascular Limited

(Registration number: 12092698)
Balance Sheet as at 31 July 2025

| Note | 2025 £ | 2024 £
Fixed assets |  |  |
Tangible assets | 3 | 3,567 | 3,818
Other financial assets | 4 | 621,707 | 580,791
|  | 625,274 | 584,609
Current assets |  |  |
Debtors | 5 | 684,186 | 147,732
Cash at bank and in hand |  | 352,101 | 594,824
|  | 1,036,287 | 742,556
Creditors: Amounts falling due within one year | 6 | (292,641) | (162,989)
Net current assets |  | 743,646 | 579,567
Total assets less current liabilities |  | 1,368,920 | 1,164,176
Creditors: Amounts falling due after more than one year | 6 | - | (12,479)
Net assets |  | 1,368,920 | 1,151,697
Capital and reserves |  |  |
Called up share capital |  | 100 | 100
Revaluation reserve |  | 99,224 | 58,308
Retained earnings |  | 1,269,596 | 1,093,289
Shareholders' funds |  | 1,368,920 | 1,151,697

For the financial year ending 31 July 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

• | The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and
• | The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 29 January 2026 and signed on its behalf by:

......................................... Prof Andrew Bradbury Director

West Midland Vascular Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 July 2025

1 | Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements were prepared in accordance with Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland and the Companies Act 2006'.

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.
The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.
The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class | Depreciation method and rate
Plant and machinery | 20% reducing balance

West Midland Vascular Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 July 2025

2 | Staff numbers

The average number of persons employed by the company (including directors) during the year, was 3 (2024 - 2).

West Midland Vascular Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 July 2025

3 | Tangible assets

| Fixtures and fittings £ | Office equipment £ | Total £
Cost or valuation
At 1 August 2024 | 2,003 | 3,585 | 5,588
Additions | - | 755 | 755
At 31 July 2025 | 2,003 | 4,340 | 6,343
Depreciation
At 1 August 2024 | 921 | 849 | 1,770
Charge for the year | 322 | 684 | 1,006
At 31 July 2025 | 1,243 | 1,533 | 2,776
Carrying amount
At 31 July 2025 | 760 | 2,807 | 3,567
At 31 July 2024 | 1,082 | 2,736 | 3,818

4 | Other financial assets (current and non-current)

| Financial assets at fair value through profit and loss £ | Total £
Non-current financial assets
Cost or valuation
At 1 August 2024 | 580,791 | 580,791
Fair value adjustments | 40,916 | 40,916
At 31 July 2025 | 621,707 | 621,707
Impairment
Carrying amount
At 31 July 2025 | 621,707 | 621,707

5 | Debtors

West Midland Vascular Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 July 2025

Current | 2025 £ | 2024 £
Trade debtors | 197,756 | 147,732
Other debtors | 486,430 | -
| 684,186 | 147,732

6 | Creditors

Creditors: amounts falling due within one year

| 2025 £ | 2024 £
Due within one year |  |
Trade creditors | 148,285 | 387
Taxation and social security | 113,266 | 134,336
Accruals and deferred income | 3,500 | 3,500
Other creditors | 27,590 | 24,766
| 292,641 | 162,989

Creditors: amounts falling due after more than one year

| Note | 2025 £ | 2024 £
Due after one year |  |  |
Loans and borrowings | 8 | - | 12,479

7 | Reserves

The changes to each component of equity resulting from items of other comprehensive income for the current year were as follows:

| Revaluation reserve £ | Total £
Surplus/deficit on revaluation of other assets | 40,916 | 40,916

The changes to each component of equity resulting from items of other comprehensive income for the prior year were as follows:

| Revaluation reserve £ | Total £
Surplus/deficit on revaluation of other assets | 58,308 | 58,308

West Midland Vascular Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 July 2025

8 | Loans and borrowings

Non-current loans and borrowings

| 2025 £ | 2024 £
Other borrowings | - | 12,479